<DOC>
	<DOCNO>NCT02029157</DOCNO>
	<brief_summary>The present clinical trial aim evaluate efficacy ARQ 197 patient hepatocellular carcinoma ( HCC ) , resistant intolerable one systemic chemotherapy regimen include sorafenib .</brief_summary>
	<brief_title>A Randomized Double-blind , Placebo-controlled Japanese Phase III Trial ARQ 197 Hepatocellular Carcinoma ( HCC )</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<criteria>Informed consent form ≥20 year old Inoperable HCC eligible locoregional therapy Diagnosed cMet high tumor sample Radiographic progression confirm systemic chemotherapy include sorafenib , intolerance chemotherapy . Eastern Cooperative Oncology Group Performance Status ( ECOG PS ) 0 1 ChildPugh Class A Having measurable target lesion define Response Evaluation Criteria Solid Tumors ( RECIST ) version 1.1 , Negative pregnancy test result Adequate organ function Life expectancy least 12 week More 2 prior systemic chemotherapy . Prior therapy cMet inhibitor ( include antibody ) Any systemic therapy within ≤2 week prior randomization Locoregional therapy within ≤4 week prior randomization . Major surgery within ≤4 week prior randomization Concurrent cancer within ≤5 year prior randomization History cardiac disease Active clinically serious infection define ≥ Grade 3 accord Common Toxicity Criteria Adverse Effects ( CTCAE ) 4.0 Any psychological disorder affect Informed Consent Diagnosis positive antiHIV antibody and/or antiHTLV1 antibody Blood albumin transfusion within ≤14 day prior screen test Concurrent interferon therapy Hepatitis B Virus ( HBV ) / Hepatitis C Virus ( HCV ) Symptomatic brain metastasis History liver transplantation Inability swallow oral medication Confirmed interstitial lung disease Pleural effusion and/or clinically significant ascites Pregnancy breastfeed Without consent effective single combine contraceptive method</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>